ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2025
Impact of injectable HAE on-demand treatments on health-related quality of life: a patient and caregiver interview study.
Article in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHereditary angioedema (HAE) attacks can be unpredictable, painful, and debilitating. Although studies described the burden of prophylactic HAE treatments on patient and caregiver health-related quality of life (HRQoL), few have explored the effects of injectable on-demand treatments on HRQoL.
objectiveTo understand the impact of injectable on-demand HAE treatments on HRQoL.
methodsPatients (aged ≥ 12 years) with ≥ 1 HAE attack in the prior 6 months and adult caregivers (aged ≥ 18 years) of patients of any age with HAE were recruited between July and October 2024 to complete a qualitative interview. Questions concerned on-demand injectable treatment use, impacts, and burden. Thematic analysis was used to identify key themes across responses.
resultsThe 25 study participants from the US and UK (17 patients; 8 caregivers), who completed the interview, highlighted emotional and logistical reasons for delaying or forgoing injectable on-demand treatment, including fear of needles, portability, and complexity of administration. All participants described at least one negative impact on HRQoL, including anxiety and pain associated with treatment administration, disruption of daily activities or work/school days, and impacts on personal relationships. Adolescent patients reported greater impacts than adult patients. Although indicated for self-administration, some adult and all adolescent patients reported needing assistance with administration of their injectable on-demand treatment. All participants expressed interest in an oral on-demand treatment for reasons including portability, pain-free administration, and ability to treat attacks earlier.
conclusionThis study highlights the unmet need for an on-demand treatment that allows for earlier, pain-free administration, ultimately increasing patient independence and improving HRQoL for both patients and caregivers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.